Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07197736 · ClinicalTrials.gov registry record

DELINEATE-Prospective

A clinical trial, sponsored by Columbia University.

Recruiting
Registry status
50
Enrollment target

NCT07197736 is a clinical trial that is actively recruiting participants, run by Columbia University. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07197736 is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
50 participants
Enrollment target

Study Summary

Heart disease is the leading cause of death in the United States, and echocardiography (or "echo") is the most common way doctors look at the heart. Echo is safe, painless, and can detect major heart problems, including weak heart pumping and valve disease. Valve disease, especially aortic stenosis (narrowing) and mitral regurgitation (leakage), is common in older adults but often goes undiagnosed. While echo is the main tool for finding valve problems, it takes time, requires expert training, and results can vary between readers. Recent advances in artificial intelligence (AI), especially deep learning (DL), have shown promise in automatically analyzing heart images. However, past research hasn't fully tackled key echo techniques-like color Doppler and spectral Doppler-that are crucial for measuring how blood moves through heart valves. AI tools also face challenges in being used in everyday medical practice because of workflow issues, lack of real-world testing, and concerns about how the algorithms make decisions. At Columbia University Irving Medical Center, researchers have built a large database of heart tests over the last six years and developed AI programs to analyze echocardiograms. The current study will test whether providing AI analysis to cardiologists in real time during echo reading can make the process faster and more consistent.

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-04-15
Est. Completion 2028-10-01

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT07197736

The ClinicalTrials.gov registry entry for NCT07197736 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT07197736 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07197736 about?

NCT07197736 is a clinical study titled "DELINEATE-Prospective". Heart disease is the leading cause of death in the United States, and echocardiography (or "echo") is the most common way doctors look at the heart. Echo is safe, painless, and can detect major heart problems, including weak heart pumping and valve disease. Valve disease, especially aortic stenosis...

What is the current status of trial NCT07197736?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-04-15. Estimated completion is 2028-10-01.

Who is sponsoring clinical trial NCT07197736?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.